Acute copper toxicity following copper glycinate injection

Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix

Every year, more Cu(II) complexes are proven to be biologically active species, but very few are developed as drugs or entered in clinical trials. This is due to their poor water solubility and lipophilicity, low stability as well as in vivo inactivation. The possibility to improve their pharmacological and/or oral administration profile by incorporation into inorganic or organic matrix was studied. Most of them are either physically encapsulated or conjugated to the matrix via a moiety able to coordinate Cu(II). As a result, a large variety of species were developed as delivery carriers. The organic carriers include liposomes, synthetic or natural polymers or dendrimers, while the inorganic ones are based on carbon nanotubes, hydrotalcite and silica. Some hybrid organic-inorganic materials based on alginate-carbonate, gold-PEG and magnetic mesoporous silica-Schiff base were also developed for this purpose.

Assessing Essential Trace Elements in Cave Nectar Bat (Eonycteris spelaea): A Study in Barak Valley of Assam, India

This study investigated trace elements in the different organs of Eonycteris spelaea, a hill cave from the Bhuban Hills of Sonai Reserve Forest, Cachar, Assam (India). Six bats were collected from the site and concentrations of four trace elements (Cu, Zn, Fe, and Mn) were examined from the tissues of liver, lungs, kidney, and patagium using graphite furnace atomic absorption spectrometer (graphite furnace model-Analytic Jena Vario-6). The results of the study revealed that concentration of essential trace elements in the body tissues of E. spelaea were less than the maximum permissible limit. During the study, it was found that the concentration of copper in all the four organs are of the following order: liver (3 ± 0.11 μg/g dw) > lungs (2.4 ± 0.14 μg/g dw) > kidney (1.8 ± 0.10 μg/g dw) > patagium (1.8 ± 0.06 μg/g dw). For zinc, this sequence was kidney (61.8 ± 0.32 μg/g dw) > liver (61.2 ± 0.14 μg/g dw) > lungs (58.8 ± 0.19 μg/g dw) > patagium (46.8 ± 0.16 μg/g dw). For manganese, kidney (1.2 ± 0.15 μg/g dw) > lungs (0.6 ± 0.13 μg/g dw) > liver (0.6 ± 0.11 μg/g dw) > patagium (0.6 ± 0.10 μg/g), and for iron, it was liver (98.4 ± 0.22 μg/g) > lungs (78.6 ± 0.47 μg/g dw) > kidney (25.8 ± 0.23 μg/g dw) > patagium (16.2 ± 0.26 μg/g dw). Analysis of variance revealed significant differences (d.f. = 15, F = 44.84, P < 0.01) in the accumulation pattern in all the studied tissues of Eonycteris spelaea.

Severe Acute Copper Sulphate Poisoning: A Case Report

As copper sulphate pentahydrate (CSP) is a common compound used in agriculture and industry, chronic occupational exposures to CSP are well known, but acute poisoning is rare in the Western world. This case report describes acute poisoning of a 33-year-old woman who attempted suicide by ingesting an unknown amount of CSP. On admission to the hospital, she had symptoms and signs of severe hemorrhagic gastroenteritis, dehydration, renal dysfunction and methaemoglobinaemia with normal serum copper level. Therapy included early gastric lavage, fluid replacement, vasoactive drugs, furosemide, antiemetic drugs, ranitidine, and antidotes methylene blue and 2,3-dimercaptopropane-1-sulphonate (DMPS). However, the patient developed severe intravascular haemolysis, acute severe hepatic and renal failure, as well as adrenal insufficiency. After prolonged, but successful hospital treatment, including haemodialysis and IV hydrocortisone, the patient was discharged with signs of mild renal and liver impairment. Our conclusion is that in severe cases of copper poisoning early supportive measures are essential. In addition, antidotes such as methylene blue for methaemoglobinaemia and chelating agent such as DMPS improve morbidity and survival of severely poisoned victims.